- Report
- July 2023
- 183 Pages
Global
From €3483EUR$3,554USD£3,030GBP
€3870EUR$3,949USD£3,366GBP
- Report
- September 2023
- 194 Pages
Global
From €4851EUR$4,950USD£4,219GBP
- Report
- July 2023
- 184 Pages
Global
From €3528EUR$3,600USD£3,069GBP
- Report
- April 2023
- 112 Pages
Global
From €4189EUR$4,275USD£3,644GBP
€4655EUR$4,750USD£4,049GBP
- Report
- April 2023
- 102 Pages
Global
From €3871EUR$3,950USD£3,367GBP
- Report
- December 2022
- 186 Pages
Global
From €4410EUR$4,500USD£3,836GBP
- Report
- June 2023
- 275 Pages
Global
From €4900EUR$5,000USD£4,262GBP
- Report
- April 2023
- 205 Pages
Global
From €7350EUR$7,500USD£6,393GBP
- Report
- May 2023
- 213 Pages
Global
From €3675EUR$3,750USD£3,197GBP
- Report
- June 2022
- 146 Pages
Global
From €2449EUR$2,499USD£2,130GBP
- Report
- September 2022
- 191 Pages
Global
From €3528EUR$3,600USD£3,069GBP
- Report
- January 2022
- 60 Pages
Global
From €3871EUR$3,950USD£3,367GBP
- Clinical Trials
- July 2021
- 60 Pages
Global
From €1470EUR$1,500USD£1,279GBP
- Clinical Trials
- February 2020
- 106 Pages
Global
From €1470EUR$1,500USD£1,279GBP
- Report
- February 2020
- 261 Pages
Global
From €5263EUR$5,370USD£4,578GBP
- Report
- January 2022
- 200 Pages
Global
From €7350EUR$7,500USD£6,393GBP
- Report
- June 2022
- 120 Pages
Global
From €2450EUR$2,500USD£2,131GBP
- Report
- March 2022
- 120 Pages
Global
From €2450EUR$2,500USD£2,131GBP
- Report
- March 2018
- 170 Pages
Global
From €5679EUR$5,795USD£4,940GBP
- Report
- August 2022
United States
From €1901EUR$1,940USD£1,654GBP

Uveitis is an inflammatory condition of the eye that can cause vision loss and other complications. Immune disorders drugs are used to treat uveitis and other immune-mediated diseases. These drugs are designed to reduce inflammation and suppress the immune system. Commonly used drugs include corticosteroids, immunosuppressants, and biologics. Corticosteroids are used to reduce inflammation and suppress the immune system, while immunosuppressants are used to reduce the activity of the immune system. Biologics are used to target specific parts of the immune system and reduce inflammation.
The uveitis drug market is a rapidly growing segment of the immune disorders drugs market. It is driven by the increasing prevalence of uveitis and other immune-mediated diseases, as well as the development of new drugs and treatments. Companies in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more